ArticleDermato-endocrinology2012
Is vitamin D status relevant to metabolic syndrome?
Article in Dermato-endocrinology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.
- Dietary magnesium intake and risk of metabolic syndrome: a meta-analysis.Diabetic medicine : a journal of the British Diabetic Association · 2014Pooled it
- Bioavailability of vitamin D2 from enriched mushrooms in prediabetic adults: a randomized controlled trial.European journal of clinical nutrition · 2014Trial
- Evidence That Increasing Serum 25(OH)D Concentrations to 30 ng/mL in the Kingdom of Saudi Arabia and the United Arab Emirates Could Greatly Improve Health Outcomes.Biomedicines · 2023Review
- Vitamin D and estrogen steroid hormones and their immunogenetic roles in Infectious respiratory (TB and COVID-19) diseases.Genetics and molecular biology · 2023Article
- Caveolin-1 (CAV-1) up regulation in metabolic syndrome: all roads leading to the same end.Molecular biology reports · 2020Article
- Exploring the Impact of Obesity on Skeletal Muscle Function in Older Age.Frontiers in nutrition · 2020Review
- Vitamin D deficiency and metabolic syndrome in elderly Chinese individuals: evidence from CLHLS.Nutrition & metabolism · 2020Article
- Genetic and non-genetic effects of increased sun and vitamin D exposure: role in the observed healthy changes in cardiometabolic risk factors in Iranian children.Public health nutrition · 2018Article
- Current Evidence on Vitamin D Deficiency and Metabolic Syndrome in Obese Children: What Does the Evidence from Saudi Arabia Tell Us?Children (Basel, Switzerland) · 2018Article
- The associations of vitamin D status and dietary calcium with the metabolic syndrome: an analysis of the Victorian Health Monitor survey.Public health nutrition · 2017Article
- Vitamin D status is inversely associated with markers of risk for type 2 diabetes: A population based study in Victoria, Australia.PloS one · 2017Article
- Article
- Low levels of serum 25-hydroxyvitamin D and risk of metabolic syndrome in China.International journal of clinical and experimental medicine · 2015Article
- Review
- Relationship between 25-hydroxyvitamin D and newly diagnosed type 2 diabetes mellitus in postmenopausal women with osteoporosis.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2014Article
- Vitamin D: Update 2013: From rickets prophylaxis to general preventive healthcare.Dermato-endocrinology · 2013Review
- Factors determining the risk of the metabolic syndrome: is there a central role for adiponectin?European journal of clinical nutrition · 2013Review
- The problems of vitamin d insufficiency in older people.Aging and disease · 2012Article
- Vitamin D: Its role in disease prevention.Dermato-endocrinology · 2012Article
- Determination of Vitamin D Status in a Population of Ecuadorian Subjects.TheScientificWorldJournalArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Review of the evidence on hypovitaminosis D as a risk factor for metabolic syndrome and its sequelae, T2DM and CVD, suggests long-term vitamin D repletion could reduce these risks. There is mechanistic evidence for protective effects for MetS and the balance of evidence, (cross-sectional and prospective), supports this postulate. Much of the data so far available from randomized controlled trials is weakened by inadequate power, low vitamin D dosages, starting supplementation too late in life or after MetS disorders have developed or, most importantly, by non-inclusion of many recognizable confounders. On balance, therefore, maintenance of US 2010 recommended intakes for bone protection has the potential to prove protective for MetS. Supplementation has been shown to increase survival in patients with cardiac disorders; whether higher doses would provide useful protection for apparently healthy people in the general population awaits the outcomes of ongoing randomized-controlled trials that, it is hoped, will prove or disprove causality for hypovitaminosis D in MetS and its long-term ill-effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.